Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate CAS 205448-66-4 Mama >98.0% (HPLC) Lenvatinib Mesylate Intermediate Factory
Ruifu Chemical Supply Lenvatinib Mesylate Intermediates ma maualuga mama
Lenvatinib Mesylate CAS 857890-39-2
4-Chloro-7-Methoxyquinoline-6-Carboxamide CAS 417721-36-9
Desquinolinyl Lenvatinib;1-(2-Chloro-4-Hydroxyphenyl)-3-Cyclopropylurea CAS 796848-79-8
Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate CAS 205448-65-3
Methyl 4-Amino-2-Methoxybenzoate CAS 27492-84-8
5-(Methoxymethylene)-2,2-Dimethyl-1,3-Dioxane-4,6-Dione CAS 15568-85-1
4-Amino-3-Chlorophenol CAS 17609-80-2
4-Amino-3-Chlorophenol Hydrochloride CAS 52671-64-4
Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate CAS 205448-66-4
Igoa Vailaau | Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate |
Synonyms | Lenvatinib Le mama 47;4-Chloro-7-Methoxyquinoline-6-Carboxylic Acid Methyl Ester;4-Chloro-7-Methoxy-6-Quinolinecarboxylic Acid Methyl Ester;Lenvaint-D |
Numera CAS | 205448-66-4 |
CAT Numera | RF-PI1970 |
Tulaga Fa'asoa | I Fa'atauga, Oloa Fua e O'o i Tone |
Fuafua mole | C12H10ClNO3 |
Molecular Weight | 251.67 |
Fa'apuna | 377.4±37.0℃ |
Malosi | 1.320±0.06 g/cm3 |
Fa'ailoga | Ruifu Chemical |
Aitema | Fa'amatalaga |
Fa'aaliga | Pa'epa'e-Pa'epa'e ile Pa'u Samasama |
1 H NMR Alaleo | Osi ma le Fauga |
Mama / Suʻesuʻega Metotia | >98.0% (HPLC) |
Ma'imau ile Fa'amago | <1.00% |
Aofa'i Fa'aleaga | <2.00% |
Tulaga Su'ega | Pisinisi Tulaga |
Fa'aoga | Vaeluaga/le mama ole Lenvatinib Mesylate (CAS: 857890-39-2) |
afifi: Fagu, ato pepa alumini, 25kg/Kati Pusa, pe tusa ai ma manaoga o tagata faatau
Tulaga teuina:Teu i totonu o pusa faʻamaufaʻailoga i se nofoaga malulu ma mago;Puipui mai le malamalama ma le susu
Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate (CAS: 205448-66-4) o se vaeluaga ole Lenvatinib Mesylate (CAS: 857890-39-2).Lenvatinib o se vailaʻau o le kanesa thyroid na atiaʻe e le Eisai Corporation o Iapani (Code: E7080), o loʻo iai i le inhibitor of oral multi-receptor tyrosine kinase (RTK) ma e mafai ona faʻalavelaveina le gaioiga o le kinase o le vascular endothelial growth factor Receptors R1 (FLT1), VEG-FR2 (KDR), R3 (FLT4).Lenvatinib e mafai foi ona taofia le aʻafia o isi RTK i pathological angiogenesis, tuputupu aʻe o le tuma, ma le alualu i luma o le kanesa sei vagana ai a latou galuega masani feaveaʻi e aofia ai le fibroblast growth factor (FGF) receptors FGFR1, 2, 3, ma le 4;e maua mai le platelets growth factor receptor (PDGFR [alpha]), KIT, ma le RET.[Fa'ailoga]: Lenvatinib e talafeagai mo togafitiga o gasegase o thyroid kanesa o le toe fa'afo'i mai i le lotoifale po'o le metastasis ituaiga, tulaga alualu i luma ma le radioactive iodine-refractory differentiated type.